All In Biotech

Drug Trial Radar · NCT04325776

A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis

A Randomized, Double-blind and Imitation, Parallel-control, Multicenter Phase II Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC) With Bone Metastasis

Last checked: Nov 19, 2026Latest source record: Oct 12, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

60

Planned (sponsor's estimate)

Start

Sep 24, 2020

Primary completion

May 2021

Study completion Nov 2021

Sponsor

Sponsor type
Industry
First posted
Mar 30, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

AL2846 is a multi-target tyrosine kinase receptor inhibitor with obvious selective to c-met, suggesting that its anti-tumor effect mainly inhibits the activation of key downstream oncogenic pathways by inhibiting expression of c-met, tumor angiogenesis and tumor cell migration.

Conditions

  • Bone Metastatic Non-small Cell Lung Cancer

Interventions

  • AL2846Drug

    AL2846 is a multi-target tyrosine kinase receptor inhibitor with obvious selective to c-met.

  • Zoledronic Acid InjectionDrug

    Zoledronic acid is a bisphosphonate drug that has a strong inhibition of bone resorption and a potential to promote bone formation, and can be used for bone metastasis caused by malignant tumors.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The time when the first bone-related event (SRE) occurredTime frame: up to 96 weeks

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Anhui Chest Hospital

    Hefei, Anhui, China · Recruiting

  • Henan Cancer Hospital

    Zhengzhou, Henan, China · Recruiting

  • China-Japan Union Hospital Of Jilin University

    Changchun, Jilin, China · Not yet recruiting

  • Jinzhou Central Hospital

    Jinzhou, Liaoning, China · Recruiting

  • Shenyang Chest Hospital

    Shenyang, Liaoning, China · Recruiting

  • Sir Run Run Shaw Hospital (SRRSH)

    Hangzhou, Zhejiang, China · Recruiting

  • The First Hospital of Jiaxing

    Jiaxing, Zhejiang, China · Not yet recruiting

  • Quzhou People's Hospital

    Quzhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.